USPTO trademark

EXGILIA

RegisteredUSPTOWord markClass 5

"EXGILIA" is a word mark owned by Ipsen Pharma S.A.S., filed at the USPTO on July 8, 2026. It is registered and covers class 5 (Pharmaceuticals).

Official USPTO record
EXGILIA trademark as filed
As filed with the USPTO
Status
Registered
Since October 27, 2026
Filed
July 8, 2026
Registered
October 27, 2026
Expires
Not recorded
Application no.
99928541
Registration no.
8524161
Office
USPTO
United States Patent and Trademark Office
Mark type
Word mark
1 class
Ownership

Who owns EXGILIA

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Goods and services

What the mark covers

The products and services EXGILIA is filed for, grouped by Nice class.

  • Pharmaceutical preparations for use in the diagnosis, treatment, or prevention of cancer, orphan diseases, immune disorders, liver diseases, biliary diseases, metabolic diseases, inflammatory diseases, urological diseases, disorders and diseases of the reproductive system, puberty related diseases or disorders, gynecological disorders, fertility, acromegaly and tumors, hormonal disorders, endocrine disorders, connective tissue diseases, blood diseases, hematological diseases and disorders, gastrointestinal diseases and disorders, hemophilia, gastrointestinal bleeding disorders, neurological diseases and disorders, muscle disorders, bone disorders, skeletal disorders, peripheral nervous system disorders, neuromuscular disorders, cervical dystonia, cerebral palsy, spasticity, blepharospasm, migraine, bladder pain syndrome, pain; pharmaceutical preparations for aesthetic and therapeutic use, including for the diagnosis, treatment, or prevention of glabellar lines, forehead lines, lateral canthal lines, facial wrinkles, asymmetries and defects and conditions of the human skin; pharmaceutical preparations for skin care.

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Notice of registration confirmation emailed
  2. Registered-principal register
  3. Official gazette publication confirmation e-mailed
  4. Published for opposition
  5. Notification of notice of publication e-mailed
  6. Approved for pub - principal register
  7. Teas/email correspondence entered
  8. Correspondence received in law office
  9. Teas response to office action received
  10. Notification of non-final action e-mailed

6 earlier steps on the official record.

FAQ

About EXGILIA

Who owns the trademark "EXGILIA"?

The USPTO trademark "EXGILIA" (application 99928541) is owned by Ipsen Pharma S.A.S.

What is the status of "EXGILIA"?

Its status at the USPTO is: registered.

When was "EXGILIA" registered?

It was registered on October 27, 2026.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull EXGILIA and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

GET /v1/trademarks/{id}
ID=tm_019f4701-43b8-727e-9eea-f44307a24a27
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019f4701-43b8-727e-9eea-f44307a24a27",
  "object": "trademark",
  "mark_text": "EXGILIA",
  "status": {
    "primary": "active",
    "stage": "registered"
  },
  "office_code": "US",
  "application_number": "99928541",
  "filing_date": "2026-07-08",
  "nice_classes": [
    5
  ],
  "owners": [
    {
      "name": "Ipsen Pharma S.A.S.",
      "entity_id": "ent_019eb6f9-ad85-75c4-94ee-581599ed8d81"
    }
  ]
}